0001209191-21-000482.txt : 20210104 0001209191-21-000482.hdr.sgml : 20210104 20210104180139 ACCESSION NUMBER: 0001209191-21-000482 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jayne David R.W. CENTRAL INDEX KEY: 0001838242 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 21503134 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: BC V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-01-01 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001838242 Jayne David R.W. #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Stock 30000 D Stock Option (right to buy) 3.62 2027-02-16 Common Stock 10000 D Stock Option (right to buy) 6.95 2027-02-16 Common Stock 20000 D Stock Option (right to buy) 5.14 2028-02-05 Common Stock 30000 D Stock Option (right to buy) 6.06 2029-01-20 Common Stock 30000 D Stock Option (right to buy) 6.42 2029-07-03 Common Stock 15000 D Stock Option (right to buy) 15.75 2030-06-02 Common Stock 30000 D The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. The shares subject to the option vest in twelve equal monthly installments from the grant date. /s/ Stephen Robertson, Attorney-in-Fact for David R.W. Jayne, M.D. 2021-01-04 EX-24.3_952897 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of JOSEPH MILLER, STEPHEN ROBERTSON, JOHN MCKENNA and ROSE MCKINLEY, signing individually, the undersigned's true and lawful attorneys-in-fact and agents to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of AURINIA PHARMACEUTICALS INC. (the "Company"), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder and a Form ID, Uniform Application for Access Codes to File on EDGAR; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5 or Form ID (including any amendments thereto) and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company or Cooley LLP. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of December 16, 2020. /s/ David R.W. Jayne David R.W. Jayne, M.D.